Jurox is an integrated developer of animal health products which are sold worldwide, all made in its plant in Rutherford. It is exclusively animal health orientated at this time. It develops and researches its own products then have a regulatory team that takes it through to product registration in North America, Japan, Asia, UK and Europe. It also synthesises its major products in a plant at Rutherford, that product is Alfaxan and the raw material for it is Alfaxalone. It has approx 300 international registrations around the world for a range of products that it sells, both in companion animals ie dogs and cats and farm animals – dairy, beef cattle, sheep etc.
SIZE BY EMPLOYEES
In Australia Jurox has 160 employees of which 27 are in research and regulatory and 57 in operations, 32 sales and marketing Australia, 5 sales and marketing NZ, 29 sales and marketing and technical services USA 16 sales and marketing UK and soon to be expanded to western Europe, quality 26 and admin 18.
MEDTECH INDUSTRY SELF-CLASSIFICATION
The world. The biggest market for Jurox is Australia followed by the United States and the UK where it has an operation. Jurox operates in Australia through open selling distribution companies and specialist veterinary wholesale companies which it also does in New Zealand. In North America Jurox goes through established wholesalers in the veterinary space. In Canada it uses a distributor and has two researchers operating in Canada.
Jurox collaborates with Universities and research organisations to generate research for global markets. It has a close relationship with the University of Queensland as well as relationships with many overseas universities through its Head of Research, located in Vancouver, Canada.
Veterinary drugs, the bulk of them sterile injectables, and large volume suspensions for use in large animals.